Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thames Water appoints new CFO as recapitalisation plan begins

(Sharecast News) - Struggling utility group Thames Water has appointed the former finance boss of Pennon and Anglian Water as its new chief financial officer, less than a week after the abrupt resignation of its CFO and the selection of a "preferred partner" to help the company avoid nationalisation. Steve Buck, who also worked for Centrica for 11 years as well as a stint at Thames Water between 2005 and 2007, is to rejoin the company on 7 April.

His appointment follows last Friday's surprise departure of finance chief Alastair Cochran, who handed in his resignation amid a cash crunch for the company, as it struggles with a near-£20bn debt pile and looming financial obligations.

Then on Monday, Thames Water announced it had selected US investment firm KKR to take a stake in the business in an attempt to avoid nationalisation amid eye-watering bill increases for its customers.

KKR, which is already a minority shareholder in Northumbrian Water, was among several companies interested in partnering with Thames. Five others expressed an interest, according to the company.

Thames Water chief executive Chris Weston said Buck's appointment comes at "a pivotal moment for the business".

"He will play a crucial role as we seek to place Thames on a more secure financial foundation, continue to implement our turnaround plan and focus on a full recapitalisation of the business," Weston said.

Buck, who will receive an annual salary of £500,000 in his new role and a bonus of up to 156%, said: "I am looking forward to returning to Thames Water.

"Working with the team I will be focused on delivering the company's turnaround plan, and deliver the recapitalisation of the business, in order to put the business on a firmer financial platform so that we can improve performance and ensure we meet the expectations of our customers, colleagues and wider stakeholders."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.